This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biostar Pharmaceuticals Inc (BSPM)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 809.05K -20.00M 12.17M 17.38M
Operating Gains/Losses -1.17M 0.00 -1.30M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 4.20M 6.63M -5.33M -8.06M
(Increase) Decrease in Inventories 43.46K 535.58K -609.97K -11.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -1.45M 3.20M -1.64M 310.45K
(Decrease) Increase In Other Current Liabilities -401.75K -2.19M -1.20M 978.26K
(Increase) Decrease In Other Working Capital 0.00 0.00 270.49K 424.80K
Other Non-Cash Items 3.26M 10.32M 5.54M 868.72K
Net Cash From Continuing Operations 8.91M -3.58M 8.77M 12.84M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 8.91M -3.58M 8.77M 12.84M
Sale of Property, Plant & Equipment 3.39M 1.79M 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -982.01K -32.87K -3.23M -4.00M
Acquisitions 0.00 -823.88K -3.11M -4.54M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -6.62M -18.22M 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -4.21M -17.29M -6.34M -8.54M
Issuance of Debt 0.00 4.75M 787.12K 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 0.00 0.00 37.54K
Repayment of Long-Term Debt -4.84M -792.19K 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -1.61M 1.58M 0.00 0.00
Net Cash From Financing Activities -6.46M 5.55M 787.12K 37.54K
Effect of Exchange Rate Changes 80.22K 114.43K 539.70K 292.42K
Net Change in Cash & Cash Equivalents -1.68M -15.21M 3.76M 4.63M
BSPM News

BSPM Biostar Pharmaceuticals Inc

Analysts Ratings for BSPM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BSPM ANALYST REPORT

Brokerage Partners

BSPM Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs